Skip to main content
. Author manuscript; available in PMC: 2015 May 26.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2008 Aug;17(8):2087–2096. doi: 10.1158/1055-9965.EPI-08-0054

Table 2. Concordance between tumor HPV DNA and anti-HPV antibodies.

Antibodies HPV-16 DNA negative
HPV-16 DNA positive
κ statistic (95% CI)
n = 106 (%) n = 37 (%)
HPV-16 VLP
 Negative 82 (77) 14 (38) 0.36 (0.20-0.53)
 Positive 24 (23) 23 (62)
HPV-16 E6
 Negative 103 (97) 12 (32) 0.70 (0.56-0.84)
 Positive 3 (3) 25 (68)
HPV-16 E7
 Negative 103 (97) 13 (35) 0.68 (0.54-0.82)
 Positive 3 (3) 24 (65)
HPV-16 E6 and/or E7
 Negative 101 (95) 9 (24) 0.74 (0.61-0.87)
 Positive 5 (5) 28 (76)

NOTE: HPV DNA results from paraffin-embedded tissues available for 145 patients at the time of analysis; two cases were excluded because their tumors were detected with HPV-33.